The Valley Desk

NCT00215605 · Interventional trial

Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies

Overall registry status Completed

Phase 1

Conditions Cancer, Lymphoma, Thyroid Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov